Top of this page
Skip navigation, go straight to the content

Science & Technologies

UCB is an R&D driven company, investing more than 25% of sales in R&D every year. Research is the lifeblood of UCB's future and is vital to the organisation.

 

The strength of our science and technologies is based on:

  • A strong understanding of selected therapy areas and disease targets 
  • An efficient use of various technologies for the development of breakthrough medicines 
  • Embracing innovation in drug development to push the boundaries of R&D

 

Fundamental to our philosophy, is connecting science in new ways; notably chemistry and biology.

Some of our innovations

Antibody Technology

Gene-To-Drug Research

A2HitTM (Antibody to Hit)

Hit Discovery

Computer Assisted Drug Discovery

Multi-Column Chromatography

SV2A research

Genomics Technology